Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Iikki
    Junior Member
    • Sep 2015
    • 3

    #1

    Sample pooling, do FFPE derived samples need to be separate from blood derived?

    Hi!

    We sequence both blood/fresh frozen and FFPE derived exomes using the Illumina HiSeq2000 and HiSeq4000. After the sample prep the samples are pooled. We have always pooled FFPE derived samples separate from blood/FF derived, since FFPE samples tend to produce a bit less data and we have been worried that the amount of data from these samples would be further reduced when competing with better quality DNA. I have no idea why this would happen though. The molecules bind through their adapter sequences, which are the same and "fresh" regardless of tissue of origin, and the amount of input material on the flow cell is naturally the same. Does anyone have experience on running FFPE and blood/FF samples on the same lane or any idea why we should not do this?

    BR, Iikki
  • kerplunk412
    Senior Member
    • Jun 2012
    • 119

    #2
    As you noted, unless you are doing PCR-free library prep, the samples you put onto the sequencer are all fresh, high-quality PCR products and thus the type of starting material shouldn't really matter. That being said, shorter library molecules do form clusters more efficiently, so that should be taken into account when mixing.

    It makes sense to me that the FFPE samples would have lower mapping rates and more errors, so you may need to sequence them deeper to achieve the same data quality as the blood samples. However the actual clustering efficiency of the samples should not be any different, assuming PCR was used in the library preps.

    Comment

    • Iikki
      Junior Member
      • Sep 2015
      • 3

      #3
      Thank you kerplunk412!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:13 AM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 10:48 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...